Common adverse effects of Semaglutide injections include nausea, vomiting, diarrhea, constipation, stomach pain, bloating, headache, and reduced appetite
Liraglutide, a long-acting human glucagon-like Peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes
GLP-1 receptor agonists, the drug class that includes semaglutide (sold as Ozempic and Wegovy), appear to reduce cravings, lower overdose risk and decrease substance use disorder diagnoses in real-world studies
These reviews highlight not just the medications success, but also peoples journeys and success stories
However, you should discuss intermittent fasting with your doctor before you start
SURPASS-CVOT (cardiovascular outcomes in diabetes): tirzepatide vs dulaglutide in adults with type 2 diabetes and high cardiovascular risk